The biotechnology company Viralgen recently presented its new laboratory complex located in the Miramon Technology Park (Donostia-San Sebastian).
In this ambitious project, the company Flexbrick also played a leading role, providing innovative solutions in the field of construction. Flexbrick, a specialist in flexible ceramic systems, was responsible for designing and supplying the architectural envelope of Viralgen’s laboratory complex.
Viralgen, a San Sebastian-based company specializing in the production of viral vectors for gene therapy, was acquired in 2020 by the multinational pharmaceutical company Bayer. The new facilities, to which Flexbrick contributed its expertise in the architectural envelope, will enable it to increase its current production capacity fivefold and meet the growing demand for gene therapies. These therapies are aimed at addressing cancer, neurodegenerative diseases, and rare diseases of genetic origin. The laboratories have required an investment of 70 million euros, which will be increased to 120 million euros in the second phase and will employ a total of 130 specialists.
The collaboration between Viralgen and Flexbrick in this project has been key to achieving state-of-the-art facilities that will boost the research and production of gene therapies to benefit society’s health and welfare.